Pharma Mar, S.A. (PHM.MC)
MCE - MCE Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 32.70 |
| Open | 32.64 |
| Bid | 32.04 x 0 |
| Ask | 32.16 x 0 |
| Day's range | 31.82 - 32.80 |
| 52-week range | 26.16 - 43.92 |
| Volume | |
| Avg. volume | 41,199 |
| Market cap | 555.768M |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 289.27 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.65 (2.04%) |
| Ex-dividend date | 12 June 2024 |
| 1y target est | N/A |
- PR Newswire
PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer
PharmaMar (MSE: PHM), world leader in the discovery, development and commercialization of marine-derived cancer treatments, presented data from a Phase II trial evaluating PharmaMar's lurbinectedin in combination with irinotecan in patients with relapsed Small Cell Lung Cancer (SCLC) after prior platinum-based treatment at the American Society of Clinical Oncology (ASCO) meeting, which took place from 31st May to 4th June in Chicago, United States.
© 2024 Yahoo. All rights reserved.